Quasispecies analysis of HBV strains isolated from chronic hepatitis B patients treated with Peg-interferon plus Tenofovir therapy

被引:0
|
作者
Lada, Olivier [1 ,2 ]
Zhang, Qian [1 ,2 ]
Laouenan, Cedric [3 ]
Martinot-Peignoux, Michelle [1 ,2 ]
Lapalus, Martine [1 ,2 ]
Estrabaud, Emilie [1 ,2 ]
Boyer, Nathalie [1 ,2 ]
Asselah, Tarik [1 ,2 ]
Marcellin, Patrick [1 ,2 ]
机构
[1] Hop Beaujon, Clichy, France
[2] Hop Beaujon, INSERM, U773, CRB3, Clichy, France
[3] Univ Paris 07, INSERM, UMR 738, UFR Med, Paris, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1065
引用
收藏
页码:722A / 723A
页数:2
相关论文
共 50 条
  • [21] In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection
    Sprengers, D.
    van der Molen, R. G.
    Binda, R.
    Kusters, J. G.
    de Man, R. A.
    Niesters, H. G. M.
    Schalm, S. W.
    Janssen, H. L. A.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 743 - 749
  • [22] Impact of liver steatosis on virological response in elderly Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin
    Fabris, P
    Floreani, A
    Carlotto, A
    Baldo, V
    Bozzola, L
    Giordani, MT
    Negro, F
    Rassu, M
    Tramarin, A
    de Lalla, F
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (09) : 1173 - 1178
  • [23] Treatment of chronic hepatitis delta with PEG-interferon alpha-2b.
    Castelnau, C
    Gordien, E
    Boyer, N
    Martinot, M
    Deny, P
    Marcellin, P
    HEPATOLOGY, 2004, 40 (04) : 675A - 675A
  • [24] miR-155 regulates dendritic cell activation in chronic hepatitis B virus (CHBV) infected patients on Tenofovir plus Peg Interferon Therapy
    Trehanpati, Nirupma
    Khosla, Ritu
    David, Paul
    Sehgal, Rashi
    Vyas, Ashish
    Khanam, Arshi
    Prashar, Anupama
    Hissar, Syed
    Ramakrishna, Gayatri
    Sarin, Shiv K.
    HEPATOLOGY, 2013, 58 : 419A - 419A
  • [25] Comparative analysis of Peg-Interferon alpha-2b and Lamivudine in the treatment of chronic hepatitis B patients: Preliminary results
    Koliouskas, D
    Sidiropoulos, I
    Masmanidou, M
    Dokas, S
    Ziakas, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 237 - 238
  • [26] Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
    Zheng, Caixia
    Yan, Honghong
    Zeng, Jianyong
    Cai, Shaohang
    Wu, Xiaolu
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 845 - 854
  • [27] Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B:: HBsAg loss is associated with HBV genotype
    Flink, HJ
    van Zonneveld, M
    Hansen, BE
    de Man, RA
    Schalm, SW
    Janssen, HLA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02): : 297 - 303
  • [28] Peg-interferon lambda Treatment induces robust innate and adaptive immunity in chronic hepatitis B Patients
    Phillips, Sandra
    Mistry, Sameer
    Riva, Antonio
    Cooksley, Helen
    Hadzhiolova-Lebeau, Tanya
    Plavova, Slava
    Katzarov, Krum
    Simonova, Marieta
    Zeuzem, Stephan
    Woffendin, Clive
    Chen, Pei-Jer
    Peng, Cheng-Yuan
    Chang, Ting-Tsung
    Lueth, Stefan
    De Knegt, Robert
    Choi, Moon-Seok
    Wedemeyer, Heiner
    Dao, Michael
    Kim, Chang-Wook
    Chu, Heng-Chen
    Wind-Rotolo, Megan
    Williams, Roger
    Cooney, Elizabeth
    Chokshi, Shilpa
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [29] Acquired endocrine disorders after peg-interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Wang, T-E
    Chen, M-J
    Liou, T-C
    Wang, H-Y
    Chu, C-H
    Chen, C-J
    Hu, K-C
    Shih, S-C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A181 - A182
  • [30] Predictive graphical model, network-based medical tool for the prognosis of chronic hepatitis C patients treated with peg-interferon plus ribavirin
    Trapero-Marugan, M.
    Marin, M.
    Pivel, J. P.
    Del Rio, J. M.
    Nunez, O.
    Clemente, G.
    Gisbert, J. P.
    Moreno-Otero, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (04) : 468 - 474